Wayne Lam (@waynelam_urol) 's Twitter Profile
Wayne Lam

@waynelam_urol

Consultant Urologist | Prostate & Penile Cancer | Reconstructive/Prosthetic Urology | Robotic Surgery | HoLEP | Rezum | Stones | My views | RT≠E

ID: 3348012119

linkhttps://www.linkedin.com/in/wayne-lam-1a517936 calendar_today27-06-2015 21:32:45

2,2K Tweet

1,1K Takipçi

755 Takip Edilen

Steffi Yuen (@steffiyuen) 's Twitter Profile Photo

🔥#IRP #realtime monitor plots the lifeline of #RIRS in the future? How/will #integratedSuctionIrrigation help #RIRS in the future? Join us uaa2024bali with Prof Bhaskar Somani DrG #ProfYasserFarahat 🔥not to be missed: 6Sept @Uluwata7 1315-1415 ZSR Biomedical #fansofFANS 🪭

St George's Urology (@georgesurology) 's Twitter Profile Photo

Advert out for our The Royal College of Surgeons of England accredited 🤖 fellowship in Urooncology for Oct 2025. Access to Robotic Pelvic, Upper Tract and Female/Functional Reconstructive surgery. >550 cases/yr incl. extraperitoneal ERUS Robotic Urology BAUS Intuitive European Association of Urology (EAU) nhsjobs.com/job/UK/London/…

BJU International (@bjuijournal) 's Twitter Profile Photo

Bladder sparing therapy, in carefully selected patients with BCG-unresponsive #BladderCancer, provides comparable survival in the intermediate term to upfront radical cystectomy. Jake Taylor, MD, MPH doi.org/10.1111/bju.16…

Bladder sparing therapy, in carefully selected patients with BCG-unresponsive #BladderCancer, provides comparable survival in the intermediate term to upfront radical cystectomy.
<a href="/doctorjakeuro/">Jake Taylor, MD, MPH</a>
doi.org/10.1111/bju.16…
Ben Challacombe (@benchallacombe) 's Twitter Profile Photo

Just your Standard case!- Alberto Breda in a suit in Bordeaux ERUS Robotic Urology #erus24 meeting does a partial nephrectomy with the Edge SP1000 robot on a patient in Beijing, China in from of 1000 delegates with 0.130 sec delay. Amazing!

Just your Standard case!- <a href="/AlbertoBreda1/">Alberto Breda</a> in a suit in Bordeaux <a href="/ERUSrobotics/">ERUS Robotic Urology</a> #erus24 meeting does a partial nephrectomy with the Edge SP1000 robot on a patient in Beijing, China in from of 1000 delegates with 0.130 sec delay. Amazing!
NEJM (@nejm) 's Twitter Profile Photo

Neoadjuvant chemotherapy plus durvalumab, followed by adjuvant durvalumab after cystectomy, led to event-free survival superior to that with neoadjuvant chemotherapy followed by cystectomy alone. Full NIAGARA trial results: nej.md/4gmAqk3 #ESMO24

Neoadjuvant chemotherapy plus durvalumab, followed by adjuvant durvalumab after cystectomy, led to event-free survival superior to that with neoadjuvant chemotherapy followed by cystectomy alone. 

Full NIAGARA trial results: nej.md/4gmAqk3 #ESMO24
Tom Powles (@tompowles1) 's Twitter Profile Photo

Perioperative durvalumab + neoadjuvant chemo & cystectomy in operable bladder cancer significantly delays (HR 0.68) event free survival and a 25% reduction in the risk of death. 10% ⬆️ pCR. It’s the 1st time immune therapy has an OS benefit in muscle invasive UC #ESM024 NEJM

Perioperative durvalumab + neoadjuvant chemo &amp; cystectomy in operable bladder cancer significantly delays (HR 0.68) event free survival and a 25% reduction in the risk of death. 10% ⬆️ pCR. It’s the 1st time immune therapy has an OS benefit in muscle invasive UC #ESM024  <a href="/NEJM/">NEJM</a>
Lars Dyrskjøt (@ldyrskjot) 's Twitter Profile Photo

Exited to share the first results from the TOMBOLA trial presented at #ESMO24 by Jørgen Bjerggaard. We used tumor informed (WES; ddPCR) ctDNA analysis to guide Atezolizumab treatment after cystectomy using longitudinally collected blood samples. Key findings: •CtDNA-negative

Exited to share the first results from the TOMBOLA trial presented at #ESMO24 by <a href="/JBjerggaard/">Jørgen Bjerggaard</a>. We used tumor informed (WES; ddPCR) ctDNA analysis to guide Atezolizumab treatment after cystectomy using longitudinally collected blood samples.  

Key findings:

•CtDNA-negative
Vincent Tse (@vturodynamic) 's Twitter Profile Photo

What a crazy day operating in HK’s Queen Mary Hosp. 🙏 to Wayne Lam and #DrAdaNg Thomas Wong. Including this completely everted bladder from urethra, other robotic/transvag recon cases. Productive. interesting for all. USANZ SUFU USANZ ICS

What a crazy day operating in HK’s Queen Mary Hosp. 🙏 to <a href="/WayneLam_Urol/">Wayne Lam</a> and #DrAdaNg <a href="/Thomaswong1023/">Thomas Wong</a>. Including this completely everted bladder from urethra, other robotic/transvag recon cases. Productive. interesting for all. <a href="/USANZUrology/">USANZ</a> <a href="/sufuorg/">SUFU</a> <a href="/USANZUrology/">USANZ</a> <a href="/icsoffice/">ICS</a>
Rob Calvert (@robcalvert18) 's Twitter Profile Photo

Our national audit of 877 nephroureterectomy cases showed that diagnostic URS lowered the T0 rate by 3% but added a median of 53 days to the time to definitive surgery. URS more than doubled the risk of bladder recurrence and increased the risk of early mets in >= T2 disease

The BMJ (@bmj_latest) 's Twitter Profile Photo

The response to Chris Hoy's call for wider access to prostate cancer screening has been largely uncritical. But few things are quite as vexed as screening for prostate cancer, says Margaret McCartney bmj.com/content/387/bm…

Michael Hofman (@drmhofman) 's Twitter Profile Photo

Longer follow-up from our landmark ProPSMA study just out European Urology Oncology: PSMA nodal status is prognostic! At 3 years 70% of patients without nodal involvement (N0) disease free, vs. only 46% if N1 CT-defined nodal status is not prognostic. Read the details here:

Longer follow-up from our landmark ProPSMA study just out <a href="/EurUrolOncol/">European Urology Oncology</a>:

PSMA nodal status is prognostic! At 3 years 70% of patients without nodal involvement (N0) disease free, vs. only 46% if N1 

CT-defined nodal status is not prognostic.

Read the details here:
Alastair Lamb (@lambalastair) 's Twitter Profile Photo

Just out in The BMJ, our "Uncertainties in Practice" article on #LATP vs #TRUS We highlight evidence so far, discordance between recommendations (European Association of Urology (EAU) vs NICE vs Amer. Urol. Assn.) & need for nuance (!) Not long now until TRANSLATE Trial... bmj.com/content/387/bm…👈

Just out in <a href="/bmj_latest/">The BMJ</a>, our "Uncertainties in Practice" article on #LATP vs #TRUS

We highlight evidence so far, discordance between recommendations (<a href="/Uroweb/">European Association of Urology (EAU)</a> vs <a href="/NICEComms/">NICE</a> vs <a href="/AmerUrological/">Amer. Urol. Assn.</a>) &amp; need for nuance (!)

Not long now until <a href="/TranslateTrial/">TRANSLATE Trial</a>...

bmj.com/content/387/bm…👈
Prof. Prokar Dasgupta OBE (@prokarurol) 's Twitter Profile Photo

Here is the ⁦The Guardian⁩ #CunkOnLife review I remember sending ⁦Diane Morgan⁩ into giggles which is rare! Should I stop robotic surgery and become a comic? Once you have seen this ⁦BBC iPlayer⁩ ⁦Netflix⁩ please let me know? theguardian.com/tv-and-radio/2…

King's Health Partners (@kingshealth) 's Twitter Profile Photo

Of all the great #CunkOnLife moments, our favourite was when KHP Professor of Surgery Prof. Prokar Dasgupta OBE answered 'what percentage of people have a human body?' Watch this hilarious special on Netflix and BBC iPlayer ▶️bbc.co.uk/iplayer/episod…

Of all the great #CunkOnLife moments, our favourite was when KHP Professor of Surgery <a href="/prokarurol/">Prof. Prokar Dasgupta OBE</a> answered 'what percentage of people have a human body?'
 
Watch this hilarious special on <a href="/netflix/">Netflix</a> and <a href="/BBCiPlayer/">BBC iPlayer</a> ▶️bbc.co.uk/iplayer/episod…
Steffi Yuen (@steffiyuen) 's Twitter Profile Photo

💡Combining new tech 🪭Measuring #IRP via #FANS #iMimersys and via #FURS #Hawk simulataneously. 🌟Impressed: starting off with almost the same #IRP figures from these two devices. start to differ when #FURS is drawn out with stones ✏️Interpret #IRP with care! Correlate

Tom Powles (@tompowles1) 's Twitter Profile Photo

NIAGARA’s surgical safety results #EAU25 with Jim Catto. Results show the addition of duvalumab to neoadjuvant platinum chemotherapy did not increase surgical complications or cystectomy rates.

NIAGARA’s surgical safety results #EAU25 with Jim Catto. Results show the addition of duvalumab to neoadjuvant platinum chemotherapy did not increase surgical complications or cystectomy rates.